drugset / Trial / NCT02131948

Regulation of Endogenous Glucose Production by Brain Insulin Action

NCT02131948

Phase 1 Completed 8 enrolled University Health Network, Toronto
RandomizedCrossoverSingle-blindBasic science

Summary

It is well known that the hormone insulin lowers blood glucose in part by acting directly on the liver and reducing hepatic glucose production. Animal studies have shown that the hormone insulin can act on the brain to indirectly lower glucose production by the liver. We aim to test whether this is true in humans by giving insulin intranasally. It has previously been shown that a nasal spray can deliver insulin directly to the brain without affecting circulating insulin concentration.

Timeline

Start
2013-11
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic 40 iu Intranasal

Indications